ClinicalTrials.Veeva

Menu
U

University of Wisconsin | Department of Ophthalmology and Visual Sciences - Clinical Eye Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nivolumab
Pertuzumab
DKN-01
Trastuzumab
Docetaxel
Sacituzumab
Alcohol
Tocilizumab
Nicotine
ciprofloxacin

Parent organization

This site is a part of University of Wisconsin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 73 total trials

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer (EmpowHER 208)

The purpose of this study is to see if zanidatamab is safe and effective, when combined with chemotherapy, in treating people who has Human Epidermal...

Enrolling
Breast Cancer
HER2-positive Breast Cancer
Drug: Zanidatamab
Drug: Carboplatin

In this study, researchers will learn more about the use of a higher dose of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA)....

Active, not recruiting
Spinal Muscular Atrophy
Drug: Nusinersen

To determine the safety and effectiveness of IMPEDE-FX RapidFill to increase the percentage of subjects with shrinkage of the abdominal aortic aneury...

Active, not recruiting
Aortic Aneurysm, Abdominal
Procedure: EndoVascular Aneurysm Repair
Device: IMPEDE-FX RapidFill Implants

The purpose of this research is to evaluate whether adding histotripsy to maintenance durvalumab increases immune response and to assess the safety o...

Not yet enrolling
Intrahepatic Cholangiocarcinoma
Device: Histotripsy
Procedure: Biopsy

In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melano...

Enrolling
Melanoma Stage IV
Melanoma Stage III
Drug: Nivolumab
Drug: [212Pb]VMT01

This research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sen...

Active, not recruiting
Metastasis Prostate Adenocarcinoma
Prostate Adenocarcinoma
Drug: Docetaxel
Drug: Nivolumab

Trial sponsors

University of Wisconsin (UW) logo
L
J
A
A
A
Biogen logo
Debiopharm logo
D
Duke University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems